Get Breaking Business News headlines emailed to you daily.
Biotech Stocks: Facet, InterMune lead drug stocks north Source: MarketWatch Wednesday 10th March, 2010
BOSTON (MarketWatch) -- Facet Biotech Corp. and InterMune Inc. were the lead advancers among the U.S.-traded biotech issues Wednesday, with both stocks rocketing over 60% in early trading.
